Description
Bharat Book introduces a report " Branded Generics in South East Asia " the report describes the current state-of-play, the future of branded generics and the physician.
qwertyuiopasdfghjklzxcvbnmqwer tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjk lzxcvbnmqwertyuiopasdfghjklzxcv bnmqwertyuiopasdfghjklzxcvbnm Branded Generics in South East qwertyuiopasdfghjklzxcvbnmqwer Asia: Current and Future Opportunities tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjk lzxcvbnmqwertyuiopasdfghjklzxcv bnmqwertyuiopasdfghjklzxcvbnm qwertyuiopasdfghjklzxcvbnmqwer tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmrtyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqw ertyuiopasdfghjklzxcvbnmqwertyu
To Know More...
Branded Generics in South East Asia: Current and Future Opportunities Bharat Book introduces a report " Branded Generics in South East Asia " the report describes the current state-of-play, the future of branded generics and the physician. With its fast-growing, young population and projected pharmaceutical sales in excess of $20 billion in 2014, countries in the Association of South East Asian Nations (ASEAN) represent a great opportunity for Pharma. http://www.bharatbook.com/healthcare-market-researchreports/branded-generics-in-south-east-asia-current-and-future-opportunities.html However, with regional marketing practices, uncertain production values of locally manufactured generics and a huge diversity in healthcare delivery across ten nations of varying income levels, there are also great challenges. Despite the disadvantages large multinationals face, major pharmaceutical companies are diving into the region, focusing on revenue from new chemical entities and developing ‘branded’ generics as key investments. But given regional dynamics, pro-generic legislation, inconsistent IPR enforcement and local industry protection, what are the factors that the industry can leverage to drive success? Report Overview Based on interviews with ten of the region’s most experienced industry experts, Branded Generics in S.E. Asia: Current and Future Opportunities explores why the pharmaceutical industry is focusing on branded generics and new chemical entity (NCE) revenues. Timely and packed with essential details, the report describes the current state-of-play, the future of branded generics and the physician, prescriber and patient dynamics that govern drug dispensing. By offering insight into the complex forces at work, this comprehensive report provides the critical intelligence necessary for success within the region. Can Big Pharma firmly insert itself into such a vibrant but locally-dominated market? Branded Generics in S.E. Asia: Current and Future Opportunities has the answers. Key Report Features Insight into why ASEAN markets are difficult for multinationals to penetrate Timely, targeting information on regional dynamics Discussion of ASEAN harmonization, how it is challenging regulatory and manufacturing standards and how that will impact local players The role of government intervention, particularly in pro-generic legislation The impact of local industry protection in creating barriers for multinationals Strategies the industry is employing to take advantage of quality control legislation Overview of regional economics Who Would Benefit From This Report?
This report will be of value to senior pharma directors and managers with responsibilities in the following areas: Executive management Licensing/Business development Market research and business intelligence Marketing, category and product management Key account and territory management Emerging market development Regulatory and government affairs Key Questions Answered What are the main challenges facing Big Pharma in South East Asia? How can multinationals effectively gain traction in ASEAN countries? Who is best adapting to regional conditions and how is it being done? What are the conditions favouring local producers? Who are the key decision makers and what are the factors influencing them? How can multinationals adapt to changing government regulation? What is the net benefit of establishing relationships with local companies? Key Benefits Gain insight into the complexity of the ASEAN region Deepen your understanding of the current market situation in South East Asia Find out how pro-generic legislation, local industry protection and manufacturing weaknesses have resulted in a lack of regional leaders Gain insight into why most—but not all—local companies won’t survive ASEAN harmonization Find out how success will be dependent upon quickly adapting to new regulatory standards and marketing the right branded generics to suit regional demographics For more information kindly visit : Branded Generics in South East Asia: Current and Future Opportunities Or Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Fax: + 91 22 27812290 Email: [email protected] Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/Sandhya3B http://in.linkedin.com/pub/bharat-book/3a/98/512 http://healthcareraj.blogspot.com/ Follow:
doc_965989234.doc
Bharat Book introduces a report " Branded Generics in South East Asia " the report describes the current state-of-play, the future of branded generics and the physician.
qwertyuiopasdfghjklzxcvbnmqwer tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjk lzxcvbnmqwertyuiopasdfghjklzxcv bnmqwertyuiopasdfghjklzxcvbnm Branded Generics in South East qwertyuiopasdfghjklzxcvbnmqwer Asia: Current and Future Opportunities tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjk lzxcvbnmqwertyuiopasdfghjklzxcv bnmqwertyuiopasdfghjklzxcvbnm qwertyuiopasdfghjklzxcvbnmqwer tyuiopasdfghjklzxcvbnmqwertyuio pasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmrtyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqw ertyuiopasdfghjklzxcvbnmqwertyu
To Know More...
Branded Generics in South East Asia: Current and Future Opportunities Bharat Book introduces a report " Branded Generics in South East Asia " the report describes the current state-of-play, the future of branded generics and the physician. With its fast-growing, young population and projected pharmaceutical sales in excess of $20 billion in 2014, countries in the Association of South East Asian Nations (ASEAN) represent a great opportunity for Pharma. http://www.bharatbook.com/healthcare-market-researchreports/branded-generics-in-south-east-asia-current-and-future-opportunities.html However, with regional marketing practices, uncertain production values of locally manufactured generics and a huge diversity in healthcare delivery across ten nations of varying income levels, there are also great challenges. Despite the disadvantages large multinationals face, major pharmaceutical companies are diving into the region, focusing on revenue from new chemical entities and developing ‘branded’ generics as key investments. But given regional dynamics, pro-generic legislation, inconsistent IPR enforcement and local industry protection, what are the factors that the industry can leverage to drive success? Report Overview Based on interviews with ten of the region’s most experienced industry experts, Branded Generics in S.E. Asia: Current and Future Opportunities explores why the pharmaceutical industry is focusing on branded generics and new chemical entity (NCE) revenues. Timely and packed with essential details, the report describes the current state-of-play, the future of branded generics and the physician, prescriber and patient dynamics that govern drug dispensing. By offering insight into the complex forces at work, this comprehensive report provides the critical intelligence necessary for success within the region. Can Big Pharma firmly insert itself into such a vibrant but locally-dominated market? Branded Generics in S.E. Asia: Current and Future Opportunities has the answers. Key Report Features Insight into why ASEAN markets are difficult for multinationals to penetrate Timely, targeting information on regional dynamics Discussion of ASEAN harmonization, how it is challenging regulatory and manufacturing standards and how that will impact local players The role of government intervention, particularly in pro-generic legislation The impact of local industry protection in creating barriers for multinationals Strategies the industry is employing to take advantage of quality control legislation Overview of regional economics Who Would Benefit From This Report?
This report will be of value to senior pharma directors and managers with responsibilities in the following areas: Executive management Licensing/Business development Market research and business intelligence Marketing, category and product management Key account and territory management Emerging market development Regulatory and government affairs Key Questions Answered What are the main challenges facing Big Pharma in South East Asia? How can multinationals effectively gain traction in ASEAN countries? Who is best adapting to regional conditions and how is it being done? What are the conditions favouring local producers? Who are the key decision makers and what are the factors influencing them? How can multinationals adapt to changing government regulation? What is the net benefit of establishing relationships with local companies? Key Benefits Gain insight into the complexity of the ASEAN region Deepen your understanding of the current market situation in South East Asia Find out how pro-generic legislation, local industry protection and manufacturing weaknesses have resulted in a lack of regional leaders Gain insight into why most—but not all—local companies won’t survive ASEAN harmonization Find out how success will be dependent upon quickly adapting to new regulatory standards and marketing the right branded generics to suit regional demographics For more information kindly visit : Branded Generics in South East Asia: Current and Future Opportunities Or Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Fax: + 91 22 27812290 Email: [email protected] Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/Sandhya3B http://in.linkedin.com/pub/bharat-book/3a/98/512 http://healthcareraj.blogspot.com/ Follow:
doc_965989234.doc